UBS AM’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $313M | Buy |
958,336
+222,225
| +30% | +$72.5M | 0.06% | 283 |
|
|
2025
Q1 | $199M | Buy |
736,111
+25,513
| +4% | +$6.89M | 0.05% | 363 |
|
|
2024
Q4 | $167M | Buy |
710,598
+4,367
| +0.6% | +$1.03M | 0.04% | 398 |
|
|
2024
Q3 | $194M | Sell |
706,231
-129,182
| -15% | -$35.5M | 0.05% | 359 |
|
|
2024
Q2 | $203M | Buy |
835,413
+76,763
| +10% | +$18.7M | 0.06% | 297 |
|
|
2024
Q1 | $113M | Buy |
758,650
+17,589
| +2% | +$2.63M | 0.04% | 420 |
|
|
2023
Q4 | $142M | Sell |
741,061
-33,415
| -4% | -$6.4M | 0.06% | 341 |
|
|
2023
Q3 | $137M | Buy |
774,476
+100,598
| +15% | +$17.8M | 0.06% | 325 |
|
|
2023
Q2 | $135M | Hold |
673,878
| – | – | 0.07% | 326 |
|
|
2023
Q1 | $135M | Buy |
673,878
+15,958
| +2% | +$3.2M | 0.07% | 326 |
|
|
2022
Q4 | $156M | Buy |
657,920
+54,388
| +9% | +$12.9M | 0.08% | 272 |
|
|
2022
Q3 | $121M | Buy |
603,532
+10,310
| +2% | +$2.06M | 0.07% | 312 |
|
|
2022
Q2 | $86.5M | Sell |
593,222
-11,943
| -2% | -$1.74M | 0.05% | 410 |
|
|
2022
Q1 | $98.8M | Sell |
605,165
-35,545
| -6% | -$5.8M | 0.04% | 440 |
|
|
2021
Q4 | $109M | Sell |
640,710
-4,862
| -0.8% | -$824K | 0.04% | 444 |
|
|
2021
Q3 | $122M | Buy |
645,572
+22,344
| +4% | +$4.22M | 0.05% | 371 |
|
|
2021
Q2 | $106M | Sell |
623,228
-42,301
| -6% | -$7.17M | 0.05% | 419 |
|
|
2021
Q1 | $94M | Sell |
665,529
-39,906
| -6% | -$5.63M | 0.04% | 439 |
|
|
2020
Q4 | $91.7M | Sell |
705,435
-17,790
| -2% | -$2.31M | 0.04% | 432 |
|
|
2020
Q3 | $105M | Sell |
723,225
-114,402
| -14% | -$16.7M | 0.06% | 329 |
|
|
2020
Q2 | $124M | Buy |
837,627
+6,241
| +0.8% | +$924K | 0.08% | 256 |
|
|
2020
Q1 | $90.5M | Buy |
831,386
+7,717
| +0.9% | +$840K | 0.07% | 296 |
|
|
2019
Q4 | $94.9M | Buy |
823,669
+32,360
| +4% | +$3.73M | 0.06% | 340 |
|
|
2019
Q3 | $63.6M | Sell |
791,309
-173,457
| -18% | -$13.9M | 0.04% | 447 |
|
|
2019
Q2 | $70M | Sell |
964,766
-193,372
| -17% | -$14M | 0.05% | 405 |
|
|
2019
Q1 | $108M | Sell |
1,158,138
-259,352
| -18% | -$24.2M | 0.08% | 274 |
|
|
2018
Q4 | $103M | Buy |
1,417,490
+96,532
| +7% | +$7.04M | 0.09% | 247 |
|
|
2018
Q3 | $116M | Sell |
1,320,958
-37,641
| -3% | -$3.29M | 0.09% | 254 |
|
|
2018
Q2 | $134M | Buy |
1,358,599
+17,428
| +1% | +$1.72M | 0.1% | 227 |
|
|
2018
Q1 | $160M | Sell |
1,341,171
-53,042
| -4% | -$6.32M | 0.13% | 188 |
|
|
2017
Q4 | $177M | Buy |
1,394,213
+29,816
| +2% | +$3.79M | 0.15% | 150 |
|
|
2017
Q3 | $160M | Sell |
1,364,397
-84,118
| -6% | -$9.88M | 0.15% | 149 |
|
|
2017
Q2 | $116M | Sell |
1,448,515
-282,566
| -16% | -$22.5M | 0.11% | 214 |
|
|
2017
Q1 | $88.7M | Buy |
1,731,081
+63,655
| +4% | +$3.26M | 0.09% | 247 |
|
|
2016
Q4 | $62.4M | Buy |
1,667,426
+148,664
| +10% | +$5.57M | 0.07% | 309 |
|
|
2016
Q3 | $103M | Sell |
1,518,762
-144,120
| -9% | -$9.77M | 0.11% | 212 |
|
|
2016
Q2 | $92.3M | Buy |
1,662,882
+10,959
| +0.7% | +$608K | 0.1% | 212 |
|
|
2016
Q1 | $104M | Sell |
1,651,923
-269,353
| -14% | -$16.9M | 0.12% | 183 |
|
|
2015
Q4 | $181M | Buy |
1,921,276
+9,741
| +0.5% | +$917K | 0.21% | 104 |
|
|
2015
Q3 | $154M | Buy |
1,911,535
+96,271
| +5% | +$7.74M | 0.17% | 134 |
|
|
2015
Q2 | $218M | Buy |
1,815,264
+40,972
| +2% | +$4.91M | 0.21% | 109 |
|
|
2015
Q1 | $185M | Buy |
1,774,292
+172,538
| +11% | +$18M | 0.18% | 130 |
|
|
2014
Q4 | $155M | Sell |
1,601,754
-123,055
| -7% | -$11.9M | 0.15% | 161 |
|
|
2014
Q3 | $135M | Buy |
1,724,809
+20,618
| +1% | +$1.61M | 0.13% | 170 |
|
|
2014
Q2 | $108M | Buy |
1,704,191
+34,330
| +2% | +$2.17M | 0.11% | 217 |
|
|
2014
Q1 | $112M | Buy |
1,669,861
+83,359
| +5% | +$5.6M | 0.12% | 196 |
|
|
2013
Q4 | $102M | Buy |
1,586,502
+360,743
| +29% | +$23.2M | 0.12% | 204 |
|
|
2013
Q3 | $78.5M | Sell |
1,225,759
-120,120
| -9% | -$7.69M | 0.1% | 236 |
|
|
2013
Q2 | $41.7M | Buy |
+1,345,879
| New | +$41.7M | 0.05% | 361 |
|